San Francisco-based Abridge is extending its context-aware clinical decision support to every clinician at its partner health systems, regardless of how they document patient visits.
More than 300 enterprise health systems, representing over 250 million patients, have adopted the tool since its April launch, according to an Aug. 17 news release from Abridge. Monthly active users now account for more than half of eligible clinicians, and queries per clinician have tripled in the last two months.
“Adoption of decision support has outpaced anything we’ve shipped before because it feels like a natural extension of Abridge,” Shiv Rao, MD, CEO and co-founder of Abridge and a practicing cardiologist said in the news release. “It understands the context of the patient in front of the clinician, it’s grounded in the evidence they already trust, and it connects to what they want to do next.”
The expanded tool generates pre-visit summaries, answers clinical questions using validated medical literature tied to the patient’s chart, drafts referral letters and clinician handoffs, and lets clinicians claim AMA PRA Category 1 Credit for questions they already pursue during care.
Abridge expects to support more than 100 million patient-clinician conversations across more than 300 health systems this year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
